US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

4  5  6  7    9    11  12  13  
DNA & DNA Forensic Laboratories in the US - Industry Market Research Report
11/18/2014 | published by: IBISWorld
... common. Furthermore, the long-term trend of an increasing number of babies being born outside of wedlock has bolstered industry demand for DNA paternity testing. Looking forward, the industry is expected to continue growing, as improved ...  |  read more...
USD 1,020
Gilead Sciences Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
USD 995
ICON plc (ICLR) - Financial and Strategic SWOT Analysis Review
11/25/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 300
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414
12/10/2014 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry, including Average EBITDA, Operating ...  |  read more...
USD 1,995
Immunomedics Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Immunomedics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
EFT BioTech Holdings Inc - Company Capsule
11/13/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to ...  |  read more...
USD 99
Global Cell and Tissue Analysis Products Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... of cells and tissues. Various biospecimen preparation, cell and tissue separation, and cell and tissue characterization products are used to isolate and assess cells and tissue. The predominant technologies used in cell and tissue analysis ...  |  read more...
USD 2,500
Nocturia - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
2015 United Kingdom: Research and Development On Biotechnology-Industry Forecast report
11/5/2014 | published by: PerryHope Partners
... provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the number of enterprises, establishments, turnover and employment for 2015 and 2016 using regression analysis in our modeling. and Perry/Hope ...  |  read more...
USD 425
Amgen Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Elan Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... you require to better understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Animal Feed Additives
11/1/2014 | published by: Global Industry Analysts
... for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market ...  |  read more...
USD 4,950
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
11/3/2014 | published by: MarketsandMarkets
... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ...  |  read more...
USD 4,650
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
11/3/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Transgene SA - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
China Recombinant Protein Drug Industry Report, 2014-2017
11/19/2014 | published by: Research in China
... protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. The start ...  |  read more...
USD 2,500
Conference Documentation: Advances in Cell Based Assays
11/11/2014 | published by: SMI Publishing, Ltd
... and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive ...  |  read more...
USD 788.78
North America Tissue Engineered - Skin Substitutes Market Outlook to 2020
10/31/2014 | published by: GlobalData
... Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and ...  |  read more...
USD 3,000
EU5 Tissue Engineered - Skin Substitutes Market Outlook to 2020
10/31/2014 | published by: GlobalData
... Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes ...  |  read more...
USD 3,000
Anti-CD22 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD22 Antibody. This report provides information on the therapeutic development based on the Anti-CD22 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD25 Antibody. This report provides information on the therapeutic development based on the Anti-CD25 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD274 (PD-L1) Antibody. This report provides information on the therapeutic development based on the Anti-CD274 (PD-L1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD279 (PD-1) Antibody. This report provides information on the therapeutic development based on the Anti-CD279 (PD-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD3 Antibody. This report provides information on the therapeutic development based on the Anti-CD3 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD38 Antibody. This report provides information on the therapeutic development based on the Anti-CD38 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
4  5  6  7    9    11  12  13